KR100810872B1 - 감기 치료용 조성물 - Google Patents

감기 치료용 조성물 Download PDF

Info

Publication number
KR100810872B1
KR100810872B1 KR1020047003882A KR20047003882A KR100810872B1 KR 100810872 B1 KR100810872 B1 KR 100810872B1 KR 1020047003882 A KR1020047003882 A KR 1020047003882A KR 20047003882 A KR20047003882 A KR 20047003882A KR 100810872 B1 KR100810872 B1 KR 100810872B1
Authority
KR
South Korea
Prior art keywords
delete delete
xylomethazolin
acid
salt
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
KR1020047003882A
Other languages
English (en)
Korean (ko)
Other versions
KR20040049849A (ko
Inventor
한느 아네뜨 모에스가아드
카린 뢰웬스타인 크리스텐센
Original Assignee
니코메드 덴마크 에이피에스
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 니코메드 덴마크 에이피에스 filed Critical 니코메드 덴마크 에이피에스
Publication of KR20040049849A publication Critical patent/KR20040049849A/ko
Application granted granted Critical
Publication of KR100810872B1 publication Critical patent/KR100810872B1/ko
Assigned to 셀트리온 아시아 퍼시픽 피티이. 엘티디. reassignment 셀트리온 아시아 퍼시픽 피티이. 엘티디. 권리의 전부이전등록 Assignors: 다케다 파마 에이/에스
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
  • Polyurethanes Or Polyureas (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Cosmetics (AREA)
KR1020047003882A 2001-09-18 2002-09-18 감기 치료용 조성물 Expired - Lifetime KR100810872B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200101356 2001-09-18
DKPA200101356 2001-09-18
PCT/IB2002/003828 WO2003024433A2 (en) 2001-09-18 2002-09-18 Compositions for treatment of common cold, comprising ipratropium and xylometazoline

Publications (2)

Publication Number Publication Date
KR20040049849A KR20040049849A (ko) 2004-06-12
KR100810872B1 true KR100810872B1 (ko) 2008-03-06

Family

ID=8160714

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020047003882A Expired - Lifetime KR100810872B1 (ko) 2001-09-18 2002-09-18 감기 치료용 조성물

Country Status (20)

Country Link
US (2) US7652030B2 (cg-RX-API-DMAC7.html)
EP (2) EP1446119B1 (cg-RX-API-DMAC7.html)
JP (1) JP4500045B2 (cg-RX-API-DMAC7.html)
KR (1) KR100810872B1 (cg-RX-API-DMAC7.html)
CN (1) CN1290502C (cg-RX-API-DMAC7.html)
AT (1) ATE318601T1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0212586B8 (cg-RX-API-DMAC7.html)
CA (1) CA2460140C (cg-RX-API-DMAC7.html)
DE (1) DE60209511T2 (cg-RX-API-DMAC7.html)
DK (1) DK1446119T3 (cg-RX-API-DMAC7.html)
EA (1) EA008165B1 (cg-RX-API-DMAC7.html)
ES (1) ES2259098T3 (cg-RX-API-DMAC7.html)
HU (1) HU226527B1 (cg-RX-API-DMAC7.html)
MX (1) MXPA04002500A (cg-RX-API-DMAC7.html)
NO (1) NO334441B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ531792A (cg-RX-API-DMAC7.html)
PL (1) PL208686B1 (cg-RX-API-DMAC7.html)
PT (1) PT1446119E (cg-RX-API-DMAC7.html)
SI (1) SI1446119T1 (cg-RX-API-DMAC7.html)
WO (1) WO2003024433A2 (cg-RX-API-DMAC7.html)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
DE60209511T2 (de) * 2001-09-18 2006-10-05 Nycomed Danmark Aps Zusammensetzungen zur behandlung des schnupfens, welche ipratropium und xylometazolin enthalten
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
RU2006132043A (ru) * 2004-02-06 2008-03-20 МЕДА Фарма ГмбХ унд Ко.КГ (DE) Комбинация и фармацевтический препарат для лечения ринита
WO2005084330A2 (en) * 2004-03-02 2005-09-15 Synergia Pharma, Inc. Compositions and methods for treating nasal congestion
DE102004049008A1 (de) * 2004-10-05 2006-04-06 Merck Patent Gmbh Neue Verwendung für α-Sympathomimetika mit 2-Imidazolinstruktur
MX2007007836A (es) * 2004-12-27 2007-08-20 Eisai R&D Man Co Ltd Metodo para estabilizar un farmaco anti-demencia.
DE102006023770A1 (de) * 2006-05-20 2007-11-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Treibgasfreie Aerosolformulierung für die Inhalation
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
US20090270472A1 (en) * 2008-04-25 2009-10-29 Kenneth Gould Method to use oxymetazoline to interrupt the development of the common cold syndrome
EP2414560B1 (de) 2009-03-31 2013-10-23 Boehringer Ingelheim International GmbH Verfahren zur beschichtung einer oberfläche eines bauteils
JP5763053B2 (ja) 2009-05-18 2015-08-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング アダプタ、吸入器具及びアトマイザ
WO2011064163A1 (en) 2009-11-25 2011-06-03 Boehringer Ingelheim International Gmbh Nebulizer
BR112012012475B1 (pt) 2009-11-25 2020-03-03 Boehringer Ingelheim International Gmbh Nebulizador
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
WO2011160932A1 (en) 2010-06-24 2011-12-29 Boehringer Ingelheim International Gmbh Nebulizer
EP2694220B1 (de) 2011-04-01 2020-05-06 Boehringer Ingelheim International GmbH Medizinisches gerät mit behälter
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (de) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Zerstäuber mit kodiermitteln
WO2014158119A1 (en) * 2013-03-29 2014-10-02 Santa Farma İlaç Sanayi̇ A.Ş Aqueous solution composition containing ipratropium and oxymetazoline
WO2014158118A1 (en) * 2013-03-29 2014-10-02 Santa Farma İlaç Sanayi̇ A.Ş. Suspension composition containing ipratropium and oxymetazoline
ES2836977T3 (es) 2013-08-09 2021-06-28 Boehringer Ingelheim Int Nebulizador
JP6643231B2 (ja) 2013-08-09 2020-02-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
WO2015054359A1 (en) * 2013-10-08 2015-04-16 Ebadi Mark A Methods and compositions for symptomatic reflief of the common cold
WO2015169430A1 (en) 2014-05-07 2015-11-12 Boehringer Ingelheim International Gmbh Nebulizer
IL247927B (en) 2014-05-07 2022-09-01 Boehringer Ingelheim Int Container, a device that turns a liquid into a fine spray and use
CN116036425A (zh) 2014-05-07 2023-05-02 勃林格殷格翰国际有限公司 喷雾器、指示器装置及容器
US20170348230A1 (en) * 2014-12-24 2017-12-07 Jadran-Galenski Laboratorij D.D A nasal composition containing sea water as stability-improving excipient
MX383771B (es) * 2015-12-02 2025-03-14 Pablo Cortes Borrego Combinación de oximetazolina e ipratropio en aplicación tópica nasal para el tratamiento de la tos.
US20220031739A1 (en) * 2020-07-31 2022-02-03 Eye Therapies Llc Anti-viral compositions and methods of use thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69229880T2 (de) * 1991-11-19 2000-05-04 The University Of Virginia Patent Foundation, Charlottesville Kombinierte virustatikum-antimediator-behandlung (covam) von gewöhnlichen erkältungen
IL101056A (en) 1992-02-24 1997-03-18 Res & Dev Co Ltd Composition for nasal treatment
GB9218834D0 (en) 1992-09-05 1992-10-21 Procter & Gamble Nasal spray products
ATE177941T1 (de) * 1992-12-09 1999-04-15 Boehringer Ingelheim Pharma Stabilisierte medizinische aerosollösungen
EP0780127A1 (en) 1995-12-19 1997-06-25 The Procter & Gamble Company A nasal spray containing a steroid and a antihistamine
DE19653969A1 (de) 1996-12-20 1998-06-25 Boehringer Ingelheim Kg Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
WO1998048839A1 (en) * 1997-04-30 1998-11-05 Warner-Lambert Company Topical nasal antiinflammatory compositions
CA2311530C (en) * 1998-01-30 2008-06-10 Novartis Consumer Health S.A. Nasal solutions
BR9911351A (pt) 1998-06-18 2001-03-13 Boehringer Ingelheim Pharma Formulações farmacêuticas para aerossóis com duas ou mais substâncias ativas
AU765736B2 (en) 1999-06-22 2003-09-25 Boehringer Ingelheim International Gmbh Stable xylometazoline and oxymetazoline solution
DE60209511T2 (de) * 2001-09-18 2006-10-05 Nycomed Danmark Aps Zusammensetzungen zur behandlung des schnupfens, welche ipratropium und xylometazolin enthalten

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
American review of respiratory disease, Vol.123, No.4, 1981, pp418-420
Postgraduate medical journal, Vol.63, No. SUppl.1, 1987, pp61-68

Also Published As

Publication number Publication date
BRPI0212586B8 (pt) 2021-05-25
SI1446119T1 (sl) 2006-08-31
PT1446119E (pt) 2006-07-31
ATE318601T1 (de) 2006-03-15
JP4500045B2 (ja) 2010-07-14
EP1446119B1 (en) 2006-03-01
JP2005505569A (ja) 2005-02-24
EP1661570A2 (en) 2006-05-31
US8450339B2 (en) 2013-05-28
WO2003024433A3 (en) 2004-06-10
BR0212586B1 (pt) 2013-11-19
KR20040049849A (ko) 2004-06-12
EA008165B1 (ru) 2007-04-27
ES2259098T3 (es) 2006-09-16
HK1067984A1 (en) 2005-04-22
PL370536A1 (en) 2005-05-30
BR0212586A (pt) 2004-10-13
EP1661570A3 (en) 2012-10-24
MXPA04002500A (es) 2004-11-22
DE60209511T2 (de) 2006-10-05
HUP0402075A3 (en) 2008-04-28
CA2460140C (en) 2009-09-01
US7652030B2 (en) 2010-01-26
HUP0402075A2 (hu) 2005-02-28
PL208686B1 (pl) 2011-05-31
HU226527B1 (hu) 2009-03-30
US20100093783A1 (en) 2010-04-15
CN1555263A (zh) 2004-12-15
US20040248924A1 (en) 2004-12-09
DE60209511D1 (de) 2006-04-27
NO334441B1 (no) 2014-03-03
DK1446119T3 (da) 2006-07-10
WO2003024433A2 (en) 2003-03-27
CA2460140A1 (en) 2003-03-27
CN1290502C (zh) 2006-12-20
NZ531792A (en) 2006-02-24
EA200400444A1 (ru) 2005-02-24
NO20041070L (no) 2004-05-18
EP1446119A2 (en) 2004-08-18

Similar Documents

Publication Publication Date Title
KR100810872B1 (ko) 감기 치료용 조성물
AU2012204557B2 (en) Bepotastine compositions
JP5759553B2 (ja) ベポタスチン組成物
EP3678649B1 (en) Intranasal epinephrine formulations and methods for the treatment of disease
US20160136089A1 (en) Unit dose formulations of ketorolac for intranasal administration
US20150141473A1 (en) Pharmaceutical dosage forms of tizanidine and administration routes thereof
AU2002329578B2 (en) Compositions for treatment of common cold
HK1067984B (en) Compositions comprising ipatropium and xylometazoline for treatment of the common cold
HK1092064A (en) Compositions comprising ipatropium and xylometazoline for treatment of the common cold
AU2002329578A1 (en) Compositions for treatment of common cold

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20040317

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20060612

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20070627

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20080205

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20080228

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20080228

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20110209

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 20120207

Start annual number: 5

End annual number: 5

FPAY Annual fee payment

Payment date: 20130201

Year of fee payment: 6

PR1001 Payment of annual fee

Payment date: 20130201

Start annual number: 6

End annual number: 6

FPAY Annual fee payment

Payment date: 20140205

Year of fee payment: 7

PR1001 Payment of annual fee

Payment date: 20140205

Start annual number: 7

End annual number: 7

FPAY Annual fee payment

Payment date: 20150130

Year of fee payment: 8

PR1001 Payment of annual fee

Payment date: 20150130

Start annual number: 8

End annual number: 8

FPAY Annual fee payment

Payment date: 20160127

Year of fee payment: 9

PR1001 Payment of annual fee

Payment date: 20160127

Start annual number: 9

End annual number: 9

FPAY Annual fee payment

Payment date: 20170201

Year of fee payment: 10

PR1001 Payment of annual fee

Payment date: 20170201

Start annual number: 10

End annual number: 10

FPAY Annual fee payment

Payment date: 20180201

Year of fee payment: 11

PR1001 Payment of annual fee

Payment date: 20180201

Start annual number: 11

End annual number: 11

FPAY Annual fee payment

Payment date: 20190129

Year of fee payment: 12

PR1001 Payment of annual fee

Payment date: 20190129

Start annual number: 12

End annual number: 12

FPAY Annual fee payment

Payment date: 20200129

Year of fee payment: 13

PR1001 Payment of annual fee

Payment date: 20200129

Start annual number: 13

End annual number: 13

PR1001 Payment of annual fee

Payment date: 20210127

Start annual number: 14

End annual number: 14

PR1001 Payment of annual fee

Payment date: 20211119

Start annual number: 15

End annual number: 15

PC1801 Expiration of term

Termination date: 20230318

Termination category: Expiration of duration